DE68922540D1 - Vorläufer des Hüllenglykoproteins des HIV-2 Retrovirus und verwandte Antigene. - Google Patents
Vorläufer des Hüllenglykoproteins des HIV-2 Retrovirus und verwandte Antigene.Info
- Publication number
- DE68922540D1 DE68922540D1 DE68922540T DE68922540T DE68922540D1 DE 68922540 D1 DE68922540 D1 DE 68922540D1 DE 68922540 T DE68922540 T DE 68922540T DE 68922540 T DE68922540 T DE 68922540T DE 68922540 D1 DE68922540 D1 DE 68922540D1
- Authority
- DE
- Germany
- Prior art keywords
- retrovirus
- hiv
- envelope glycoprotein
- protein
- precursors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241001430294 unidentified retrovirus Species 0.000 title abstract 4
- 208000031886 HIV Infections Diseases 0.000 title abstract 3
- 241000713340 Human immunodeficiency virus 2 Species 0.000 title abstract 3
- 101710121417 Envelope glycoprotein Proteins 0.000 title abstract 2
- 102100021696 Syncytin-1 Human genes 0.000 title abstract 2
- 239000002243 precursor Substances 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 108700004025 env Genes Proteins 0.000 abstract 1
- 101150030339 env gene Proteins 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- AIDS & HIV (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20434688A | 1988-06-09 | 1988-06-09 | |
FR8807817A FR2632644B1 (fr) | 1988-06-10 | 1988-06-10 | Antigenes precurseurs des glycoproteines d'enveloppe d'un retrovirus humain hiv-2 et antigenes presentant une parente immunologique avec ces derniers. preparation de ces antigenes. application au diagnostic |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68922540D1 true DE68922540D1 (de) | 1995-06-14 |
DE68922540T2 DE68922540T2 (de) | 1995-10-05 |
Family
ID=26226719
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE68922540T Expired - Lifetime DE68922540T2 (de) | 1988-06-09 | 1989-06-09 | Vorläufer des Hüllenglykoproteins des HIV-2 Retrovirus und verwandte Antigene. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0354072B1 (de) |
JP (1) | JP3093763B2 (de) |
AT (1) | ATE122236T1 (de) |
CA (1) | CA1341488C (de) |
DE (1) | DE68922540T2 (de) |
DK (1) | DK175668B1 (de) |
ES (1) | ES2074085T3 (de) |
HK (1) | HK167295A (de) |
PT (1) | PT90800B (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005078443A1 (en) * | 2004-02-13 | 2005-08-25 | Inverness Medical Switzerland Gmbh | Determination of infection by the immune response to a carbohydrate moiety |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0249611A4 (de) * | 1985-11-14 | 1988-04-26 | Harvard College | T-lymphotrophisches virus. |
EP0269520A3 (de) * | 1986-11-21 | 1988-08-24 | Institut Pasteur | Zum Hervorrufen von AIDS geeignetes Retrovirus vom HIV-2-Typ sowie seine Antigen- und Nukleinsäurebestandteile |
ES2104556T3 (es) * | 1987-01-16 | 1997-10-16 | Pasteur Institut | Peptidos que tienen propiedades inmunologicas de hiv-2. |
-
1989
- 1989-06-08 JP JP01144316A patent/JP3093763B2/ja not_active Expired - Lifetime
- 1989-06-09 CA CA000602364A patent/CA1341488C/fr not_active Expired - Lifetime
- 1989-06-09 AT AT89401617T patent/ATE122236T1/de not_active IP Right Cessation
- 1989-06-09 DE DE68922540T patent/DE68922540T2/de not_active Expired - Lifetime
- 1989-06-09 ES ES89401617T patent/ES2074085T3/es not_active Expired - Lifetime
- 1989-06-09 EP EP89401617A patent/EP0354072B1/de not_active Expired - Lifetime
- 1989-06-09 PT PT90800A patent/PT90800B/pt not_active IP Right Cessation
- 1989-06-09 DK DK198902843A patent/DK175668B1/da not_active IP Right Cessation
-
1995
- 1995-10-26 HK HK167295A patent/HK167295A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK167295A (en) | 1995-11-03 |
ATE122236T1 (de) | 1995-05-15 |
DK284389D0 (da) | 1989-06-09 |
DE68922540T2 (de) | 1995-10-05 |
PT90800B (pt) | 1994-11-30 |
EP0354072A1 (de) | 1990-02-07 |
PT90800A (pt) | 1989-12-29 |
CA1341488C (fr) | 2005-08-30 |
ES2074085T3 (es) | 1995-09-01 |
EP0354072B1 (de) | 1995-05-10 |
DK284389A (da) | 1989-12-10 |
JPH02119791A (ja) | 1990-05-07 |
DK175668B1 (da) | 2005-01-10 |
JP3093763B2 (ja) | 2000-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY103182A (en) | Vaccines against acquired immune deficiency syndrome. | |
MY136081A (en) | Modified hiv - 1gag p17 peptide and immunogenic composition | |
ATE64601T1 (de) | Lymphadenopathie-assoziierte huellenantigene und deren verwendungen. | |
DK513388A (da) | Peptider med immunologiske egenskaber svarende til hiv-2 virus, nucleotidsekvenser, der koder for saadanne peptider, antigene og immunogene midler indeholdende saadanne peptider samt fremgangsmaade og kit til in vitro diagnose af hiv-2 | |
CY1107570T1 (el) | Ανοσογονικα πολυπεπτιδια κωδικοποιουμενα απο μινιγονιδια mage και οι χρησεις τους | |
DE60039036D1 (de) | Hiv-peptide, antigene und impfstoffzusammensetzungen | |
EP0429477A4 (en) | Synthetic vaccine against aids virus | |
JP2001527029A5 (de) | ||
FI885296A0 (fi) | Rekombinant hiv-2 polypeptid. | |
DE68922540T2 (de) | Vorläufer des Hüllenglykoproteins des HIV-2 Retrovirus und verwandte Antigene. | |
NZ220500A (en) | Recombinant felv polypeptide; vaccine and expression vectors | |
ATE247485T1 (de) | Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus | |
ATE136789T1 (de) | Antigene eines transmembranen hüllenglycoproteins eines menschlichen retrovirus des typs hiv-2 und immunologisch verwandte antigene | |
OA08716A (fr) | Peptides susceptibles d'être reconnus par des anticorps induits contre des retrovirus d'immunodéficience humaine (virus HIV), leurs applications au diagnostic des infections dues à certains de ces virus et, le cas échéant, à la vaccination contre le sida. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |